Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

then wouldn’t it be helpful to have information from people with rare variants which cause larger or more clear susceptibilities

Absolutely, I think everyone is agreed on that. But if rare variants are really rare it is hard to get statistical data on relative prevalence. i think people are just arguing about how much weight one can give to rare variants that look a bit like what you were expecting to find when we cannoot be sure they are actually conferring risk rather than showing up by chance.
 
i think people are just arguing about how much weight one can give to rare variants that look a bit like what you were expecting to find when we cannoot be sure they are actually conferring risk rather than showing up by chance
Ah! Gotya. Thanks for clarifying.
 
Last edited:
Ok pulled together a starter set of both the studies and a few reviews of studies
 
 
 
Back
Top Bottom